Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gema de la Poza Gómez"'
Autor:
Nazaret María Pizarro Vega, Paz Valer Lopez-Fando, Gema de la Poza Gómez, Belén Piqueras Alcol, Marina Gil Santana, Paloma Ruiz Fuentes, Marcos Alfredo Rodríguez Amado, Fernando Bermejo San José
Publikováno v:
Gastroenterología y Hepatología. 46:462-466
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d10105311a2485c2966a964ac0365c2
https://doi.org/10.1016/j.gastrohep.2022.04.003
https://doi.org/10.1016/j.gastrohep.2022.04.003
Autor:
Nazaret María Pizarro Vega, Paz Valer Lopez-Fando, Gema de la Poza Gómez, Belén Piqueras Alcol, Marina Gil Santana, Paloma Ruiz Fuentes, Marcos Alfredo Rodríguez Amado, Fernando Bermejo San José
Publikováno v:
Gastroenterología y Hepatología (English Edition).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c7708bc09c85744e2b07f5deb04bd4
https://doi.org/10.1016/j.gastre.2022.04.011
https://doi.org/10.1016/j.gastre.2022.04.011
Autor:
Antonio Roman, Teresa Angueira Lapeña, Jaime Masjuan Vallejo, Gemma Arranz de la Mata, Gema de la Poza Gómez, Daniel Boixeda de Miquel
Publikováno v:
Gastroenterología y Hepatología. 32:343-345
We report the case of a female patient who was diagnosed with Vogt-Koyanagi-Harada disease at the age of 14 years and who developed myelopathy, resulting in paraparesis. A cerebral magnetic resonance imaging scan revealed the presence of T2-hyperinte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d14737240656a4d87f99c5b2dbb2428
https://doi.org/10.1016/j.gastrohep.2008.11.009
https://doi.org/10.1016/j.gastrohep.2008.11.009
Autor:
Miguel Rivero Fernández, Gemma Arranz de la Mata, Daniel Boixeda de Miquel, Manuel Vázquez Romero, Teresa Angueira Lapeña, Gema de la Poza Gómez
Publikováno v:
Gastroenterología y Hepatología. 31:643-645
Metformin is an oral antidiabetic agent frequently used to manage type II diabetes. This drug produces nonspecific gastrointestinal symptoms in 5-20% of patients and, more rarely, has also been associated with severe adverse effects such as lactic ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b905b70281ccc9347ec7a3c0d9a74487
https://doi.org/10.1016/s0210-5705(08)75812-6
https://doi.org/10.1016/s0210-5705(08)75812-6
Autor:
Gema, de la Poza Gómez, Antonio, López-San Román, Jaime, Masjuan Vallejo, Gemma, Arranz de la Mata, Teresa, Angueira Lapeña, Daniel, Boixeda de Miquel
Publikováno v:
Gastroenterologia y hepatologia. 32(5)
We report the case of a female patient who was diagnosed with Vogt-Koyanagi-Harada disease at the age of 14 years and who developed myelopathy, resulting in paraparesis. A cerebral magnetic resonance imaging scan revealed the presence of T2-hyperinte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b0248ffbf747d8784efc8ea5fea3837
https://pubmed.ncbi.nlm.nih.gov/19442412
https://pubmed.ncbi.nlm.nih.gov/19442412
Autor:
Gema, de la Poza Gómez, Miguel, Rivero Fernández, Manuel, Vázquez Romero, Teresa, Angueira Lapeña, Gemma, Arranz de la Mata, Daniel, Boixeda de Miquel
Publikováno v:
Gastroenterologia y hepatologia. 31(10)
Metformin is an oral antidiabetic agent frequently used to manage type II diabetes. This drug produces nonspecific gastrointestinal symptoms in 5-20% of patients and, more rarely, has also been associated with severe adverse effects such as lactic ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d4a3391c8127288ce3aedf07a0b2189
https://pubmed.ncbi.nlm.nih.gov/19174081
https://pubmed.ncbi.nlm.nih.gov/19174081
Autor:
G. de-la-Poza, David Olivares, Mario Calvo, Ángel Ponferrada, Pilar López-Serrano, Gema de la Poza Gómez, Yago González-Lama, D. Martin, Noemí Manceñido, J.L. Pérez-Calle, M. Chaparro, J.L. Cuño, B. Botella, Francisco Javier Bermejo, L. Ballesteros, Alicia Algaba, Carlos Taxonera, Iván Guerra, A. López-San Román, J.P. Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 7:S96
P216 Inflammatory bowel disease unclassified (IBDU) in real practice: prevalence, clinical course and therapy requirements F. Bermejo1 *, A. Algaba1, J.L. Cuno2, B. Botella3, C. Taxonera4, M. Calvo5, P. Lopez-Serrano6, L. Ballesteros7, M. Chaparro8,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8577477b45e2bbc03bab126d6d1ccda4
https://doi.org/10.1016/s1873-9946(13)60238-x
https://doi.org/10.1016/s1873-9946(13)60238-x